Evidence map›Paper›PMID 29599139›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2018

Protective Role of mPGES-1 (Microsomal Prostaglandin E Synthase-1)-Derived PGE

Huifeng Hao, Sheng Hu, Qing Wan, Chuansheng Xu, Hong Chen, Liyuan Zhu, Zhenyu Xu, Jian Meng, Richard M Breyer, Nailin Li and 3 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Regulatory Effect of PGEBiomolecules · 2025
    Article
  3. Prostanoids in Cardiac and Vascular Remodeling.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Endogenous SORedox biology · 2021
    Article
  9. The complex role of prostaglandin EAmerican journal of physiology. Regulatory, integrative and comparative physiology · 2021
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Annual Report on Sex in Preclinical Studies:Arteriosclerosis, thrombosis, and vascular biology · 2020
    Review
  15. Microfluidic endothelium-on-a-chip development, from in vivo to in vitro experimental models.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie · 2020
    Article
  16. Article
  17. Article
  18. Thrombotic Regulation From the Endothelial Cell Perspectives.Arteriosclerosis, thrombosis, and vascular biology · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Huifeng HaoFrom the State Key Laboratory of Cardiovascular Disease (H.H., S.H., Q.W., C.X., H.C., L.Z., Z.X., J.M., M.W.).
Sheng HuFrom the State Key Laboratory of Cardiovascular Disease (H.H., S.H., Q.W., C.X., H.C., L.Z., Z.X., J.M., M.W.).
Qing WanFrom the State Key Laboratory of Cardiovascular Disease (H.H., S.H., Q.W., C.X., H.C., L.Z., Z.X., J.M., M.W.).
Chuansheng XuFrom the State Key Laboratory of Cardiovascular Disease (H.H., S.H., Q.W., C.X., H.C., L.Z., Z.X., J.M., M.W.).
Hong ChenFrom the State Key Laboratory of Cardiovascular Disease (H.H., S.H., Q.W., C.X., H.C., L.Z., Z.X., J.M., M.W.).
Liyuan ZhuFrom the State Key Laboratory of Cardiovascular Disease (H.H., S.H., Q.W., C.X., H.C., L.Z., Z.X., J.M., M.W.).
Zhenyu XuFrom the State Key Laboratory of Cardiovascular Disease (H.H., S.H., Q.W., C.X., H.C., L.Z., Z.X., J.M., M.W.).
Jian MengFrom the State Key Laboratory of Cardiovascular Disease (H.H., S.H., Q.W., C.X., H.C., L.Z., Z.X., J.M., M.W.).
Richard M BreyerVanderbilt University, Nashville, TN (R.M.B.).
Nailin LiDepartment of Medicine, Karolinska Institutet, Stockholm, Sweden (N.L.).
De-Pei LiuInstitute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (D.-P.L.).
Garret A FitzGeraldDepartment of Systems Pharmacology and Translational Therapeutics, Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia (G.A.F.).
Miao WangFrom the State Key Laboratory of Cardiovascular Disease (H.H., S.H., Q.W., C.X., H.C., L.Z., Z.X., J.M., M.W.) wangmiao_frank@yahoo.com miao.wang@pumc.edu.cn.
State Key Laboratory of Hydrology-Water Resources and Hydraulic Engineering · CNState Key Laboratory of Cardiovascular DiseaseChinese Academy of Medical Sciences & Peking Union Medical College · CNKarolinska University Hospital · SEVanderbilt University · US

Funding

Pilot Study: POPULATION PHARMACOLOGYU54HL117798 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2012 to 2016
$18.5M
NHLBI NIH HHS U54 HL117798
6 · The paper itself

Abstract

objectiveDeletion of mPGES-1 (microsomal prostaglandin E synthase-1)-an anti-inflammatory target alternative to COX (cyclooxygenase)-2-attenuates injury-induced neointima formation in mice. This is attributable to the augmented levels of PGI APPROACH AND

resultsMice deficient in both IP and mPGES-1 (DKO [double knockout] and littermate controls [IP KO (knockout)]) were subjected to angioplasty wire injury. Compared with the deletion of IP alone, coincident deletion of IP and mPGES-1 increased neointima formation, without affecting media area. Early pathological changes include impaired reendothelialization and increased leukocyte invasion in neointima. Endothelial cells (ECs), but not vascular smooth muscle cells, isolated from DKOs exhibited impaired cell proliferation. Activation of EP (E prostanoid receptor) 4 (and EP2, to a lesser extent), but not of EP1 or EP3, promoted EC proliferation. EP4 antagonism inhibited proliferation of mPGES-1-competent ECs, but not of mPGES-1-deficient ECs, which showed suppressed PGE

conclusionsRemoval of the IP receptors unmasks a protective role of mPGES-1-derived PGE

Indexed as

Cell ProliferationAnimalsCell AdhesionCells, CulturedDinoprostoneDisease Models, AnimalEndothelial CellsFemaleFemoral ArteryHumansLeukocytesMaleMice, Inbred C57BLMice, KnockoutMuscle, SmoothNeointimaDinoprostoneProstaglandin-E SynthasesPtger4 protein, mousePtges protein, mousePtgir protein, mouseReceptors, EpoprostenolReceptors, Prostaglandin E, EP4 Subtypeendotheliumprostaglandin E synthasesprostaglandin receptorprostanoidvascular remodeling

Identifiers

PMID29599139
PMCPMC5920701
OpenAlexW2795277803

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.